Harness the power of microbes—and accelerate your project from idea to industrial reality. Whether you’re crafting milligram-scale therapeutic enzymes or scaling to metric-ton batches of precision-fermented proteins, our end-to-end microbial platform delivers:
- Precision Strain Engineering
AI-driven chassis design, tailored synthetic-biology hosts built around your molecule - Smart Bioreactors
PAT-driven monitoring, inline Raman & off-gas MS, real-time control via PLC/SCADA 3.0 - Seamless Downstream Processing
Continuous purification trains—chromatography, TFF, sterile fill—without surprises
Microbial Fermentation Process Development Services
We deliver end-to-end fermentation process development—tailored to your Accelerate your microbial product from concept to commercial reality with our comprehensive fermentation process development—fully customizable to your molecule’s lifecycle and seamlessly scalable from bench‑top to production.
Our Core Offerings:
- Host & Expression Platforms
E. coli CDMO systems for high‑yield therapeutic proteins and GMP‑grade plasmid DNA. - Upstream Optimization
Six Sigma and QbD‑driven DoE fermentation design to maximize titer, productivity, and robustness. - Critical Process Parameter Mapping
FMEA‑based risk assessments identify and control the key variables—pH, DO, temperature, feed rate—for reliable scale‑up. - Scale‑Up & Scale‑Down Models
Validated workflows from 1 L lab fermenters to 100 L pilot bioreactors, ensuring data‑driven consistency at every volume. - Advanced Control Strategies
Real‑time PAT monitoring (inline Raman, off‑gas MS) coupled with automated feedback loops for precision fermentation services. - Cell Harvest & Lysis Optimization
Side‑by‑side evaluation of mechanical disruption vs. chemical/enzymatic methods and tailored clarification trains. - Tech‑Transfer & Documentation
Detailed scale‑down studies, regulatory‑ready batch records, and robust SOPs to guarantee a smooth hand‑off to your manufacturing site.
With Elise Biopharma’s bacterial CDMO expertise and end‑to‑end fermentation services, you’ll shorten development cycles, mitigate scale‑up risk, and achieve consistent, high‑quality yields—from milligrams to metric tons.
Expression Hosts We Can Tune to Your Molecule
Filamentous Fungi & Co-Cultures – Aspergillus and CRISPR-edited Clostridium for carbohydrases, secondary metabolites, bioplastics; engineered consortia for multi-step pathways
Link to our–> Fungi CDMO Services
Yeasts – Pichia for glyco-engineered biologics; Saccharomyces for food aromas & industrial enzymes; Hansenula/Kluyveromyces for dairy proteins & thermostable catalysts
Bacteria – E. coli for recombinant proteins & plasmid DNA; Bacillus for GRAS enzymes & spore probiotics; Corynebacterium/Streptomyces for vitamins, antibiotics, polyketides; facultative anaerobes for live biotherapeutics
Here is link to our Bacteria Fermentation Services
Contact our team using the form below. Thank you!
Please feel free to share your microbial inquiries and project proposals with us.
Fermentation Infrastructure & Digital Insight
| Train | Working Volume | Typical Output | Key Features |
|---|---|---|---|
| Discovery Pods | 2–10 L single-use (×12) | 120 DoE runs / month | Inline Raman, auto-feed, off-gas MS |
| Pilot Suites | 20–100 L glass/stainless | 1–5 kg protein / batch | BSL-2, ATF/TFF perfusion, sterile harvest |
| Clinical GMP | 300, 1 000, 3 000 L | 5–50 kg (Ph I–III) | Class 10 000, segregated up/downstream |
| Commercial Trains | 5 000–14 500 L | 100 kg–metric ton | Redundant utilities, aerobic/anaerobic lines, digital twin |
All vessels run on PLC/SCADA 3.0 with cascading PID loops for pH/DO/antifoam, capacitance biomass probes, and cloud-based twins that predict k_La and heat loads before they happen. A 24∕7 command center of fermentation engineers and data scientists resolves deviations in hours, not days.
Downstream Purification & Finishing
High-pressure homogenization or bead-mill disruption feeds into disc-stack centrifuges, depth filters, and TFF cassettes. Multi-modal chromatography (IEX, mixed-mode, HIC, SEC) runs on single-use or stainless skids sized to match each batch. Final formats:
Aseptic ISO 5 isolators for robotic fill-finish and in-line weight checks
Bulk liquid, lyophilized cake, spray-dried powder, stabilized beadlets
Integrated Analytics & Quality Control
Online PAT data streams into our QC lab:
21 CFR Part 11 e-records and cloud-redundant batch archives
Instrumentation: UHPLC, LC-MS/MS, MALDI, CE-SDS, qPCR, validated ELISAs
Real-time dashboards for titer, purity, endotoxin, residual DNA, HCP
ICH Q1 stability chambers (–80 °C to +40 °C)
Engagement Models
- Concept → IND Sprint
Strain engineering, fed-batch/perfusion optimization, tox material & draft CMC in < 12 months - Scale-Up & Tech-Transfer
Integrate your process into our 300–3 000 L suite; gap analysis & engineering batch in 30 days - Dedicated Capacity Lease
Reserve a 5 000–14 500 L train for 6–36 months to secure launch volumes - Flexible Pilot Slots
Monthly, pay-as-you-go 20–100 L runs for start-ups hitting investor milestones
Regulatory, Sustainability & Supply Assurance
- Certifications: ISO 13485, ISO 9001, FDA-registered for IVD enzymes; full cGMP, CAPA, change-control
- Data Integrity: 21 CFR Part 11 e-records, audit-ready archives
- Green Footprint: 100 % renewable electricity by Q3 2025; closed-loop water & solvent recycling; biomass valorization
- Resilient Supply: Multi-regional seed banks, dual-sourced critical raw materials, forward utility capacity
Why Choose Elise Biopharma?
| Your Need | Elise Advantage |
|---|---|
| Rapid proof-of-concept | 120 parallel 2–10 L DoE fermentations per month = ranked strains in weeks. |
| Seamless scale-up | Digital-twin, geometrically similar vessels reproduce yields from 2 L to 14 500 L. |
| Audit-ready clinical supply | ISO-classified suites, Part 11 EBRs, and veteran QA keep inspections painless. |
| Cost-effective commercial lots | High-density fed-batch plus continuous DSP drive industry-leading COGS. |
| Long-term partnership | Capacity-lease model and tech-transfer toolkits protect IP, timelines, and margin. |
Turn Microbial Potential into Market Reality
Whether you’re expressing a next-gen therapeutic enzyme, replacing animal-derived growth factors, manufacturing plasmid DNA, or producing fermented food proteins, Elise Biopharma delivers the microbial horsepower, regulatory rigor, and commercial mindset to succeed—first time, every time.
You can email our team directly at info@elisebiopharma.com
We look forward to speaking with you.